Table 1 World Health Organization classification of acute myeloid leukemia

Acute myeloid leukemia with recurrent genetic abnormalities

Acute myeloid leukemia with t(8;21)(q22;q22), (AML1/ETO)cpn

Acute myeloid leukemia with abnormal bone marrow eosinophils and inv(16)(p13q22) or t(16;16)(p13;q22), (CBFβ/MYH11)

Acute promyelocytic leukemia with t(15;17)(q22;q12), (PML/RARα), and variants

Acute myeloid leukemia with 11q23 (MLL) abnormalities

Acute myeloid leukemia with multi-lineage dysplasia

Following myelodysplastic syndrome or myelodysplastic syndrome/myeloproliferative disease

Without antecedent myelodysplastic syndrome or myelodysplastic syndrome/myeloproliferative disease, but with dysplasia in at least 50 percent of cells in two or more myeloid lineages

Therapy-related acute myeloid leukemia and myelodysplastic syndrome

Alkylating agent/radiation-related type

Topoisomerase II inhibitor-related type (some may be lymphoid)

Others

Acute myeloid leukemia not otherwise categorized

Acute myeloid leukemia, minimally differentiated

Acute myeloid leukemia without maturation

Acute myeloid leukemia with maturation

Acute myelomonocytic leukemia

Acute monoblastic/acute monocytic leukemia

Acute erythroid leukemia (erythroid/myeloid and pure erythroleukemia)

Acute megakaryoblastic leukemia

Acute basophilic leukemia

Acute panmyelosis with myelofibrosis

Myeloid sarcoma